ID

39612

Description

Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration

Keywords

Versions (1)
  1. 2/3/20 2/3/20 -
Copyright Holder

GlaxoSmithKline

Uploaded on

February 3, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055

English

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 forms  
Re-Screening data
Description

Re-Screening data

Alias
UMLS CUI-1
C0220908
UMLS CUI-2
C1511726
Was subject re-screened for this trial?
Description

Was subject re-screened for this trial?

Data type

boolean

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
If subject was re-screened for this trial, record original Subject Number
Description

If subject was re-screened for this trial, record original Subject Number

Data type

text

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
UMLS CUI [2]
C2348585
Study Eye
Description

Study Eye

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0015392
Study Eye Identification
Description

Study Eye Identification

Data type

text

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0015392
UMLS CUI [1,3]
C0205396
Ranibizumab Injection
Description

Ranibizumab Injection

Alias
UMLS CUI-1
C1566537
UMLS CUI-2
C1272883
Date and Time of ranibizumab injection in the study eye
Description

Date and Time of ranibizumab injection in the study eye

Data type

datetime

Alias
UMLS CUI [1,1]
C1566537
UMLS CUI [1,2]
C1272883
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
UMLS CUI [2,1]
C0008972
UMLS CUI [2,2]
C0015392
Back to the top of the page

Similar models

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Re-Screening data
C0220908 (UMLS CUI-1)
C1511726 (UMLS CUI-2)
Was subject re-screened for this trial?
Item
Was subject re-screened for this trial?
boolean
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
If subject was re-screened for this trial, record original Subject Number
Item
If subject was re-screened for this trial, record original Subject Number
text
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
C2348585 (UMLS CUI [2])
Item Group
Study Eye
C0008972 (UMLS CUI-1)
C0015392 (UMLS CUI-2)
Item
Study Eye Identification
text
C0008972 (UMLS CUI [1,1])
C0015392 (UMLS CUI [1,2])
C0205396 (UMLS CUI [1,3])
Study Eye Identification
Code List
Study Eye Identification
CL Item
Right (R)
CL Item
Left (L)
Item Group
Ranibizumab Injection
C1566537 (UMLS CUI-1)
C1272883 (UMLS CUI-2)
Date and Time of ranibizumab injection in the study eye
Item
Date and Time of ranibizumab injection in the study eye
datetime
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial